Cannara Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Other Agricultural Products
  • ISIN: CA13765U2002
CAD
1.67
-0.03 (-1.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'25
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Net Sales
27.33
26.59
25.07
23.44
19.54
19.68
19.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
27.33
26.59
25.07
23.44
19.54
19.68
19.48
Raw Material Cost
22.01
22.89
21.49
22.96
19.17
18.57
18.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.06
1.17
1.25
1.19
1.56
1.53
1.39
Selling and Distribution Expenses
5.72
5.63
5.49
5.07
4.85
5.55
4.17
Other Expenses
-0.09
-0.10
-0.11
-0.09
-0.12
-0.12
-0.12
Total Expenditure (Excl Depreciation)
27.91
28.69
27.15
28.27
24.38
24.44
22.56
Operating Profit (PBDIT) excl Other Income
-0.6
-2.1
-2.1
-4.8
-4.8
-4.8
-3.1
Other Income
0.09
0.05
0.05
-0.06
2.07
0.03
0.05
Operating Profit (PBDIT)
0.78
-0.42
-0.48
-3.12
-1.25
-3.28
-1.41
Interest
1.06
1.17
1.25
1.19
1.56
1.53
1.39
Exceptional Items
7.34
7.95
6.32
9.88
6.35
2.81
6.52
Gross Profit (PBDT)
5.32
3.70
3.58
0.47
0.37
1.12
1.30
Depreciation
1.26
1.64
1.55
1.77
1.51
1.45
1.62
Profit Before Tax
5.79
4.73
3.03
3.80
2.02
-3.45
2.11
Tax
1.65
1.41
0.73
-1.95
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4.14
3.31
2.31
5.75
2.02
-3.45
2.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4.14
3.31
2.31
5.75
2.02
-3.45
2.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4.14
3.31
2.31
5.75
2.02
-3.45
2.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
98.59
94.19
90.58
87.95
81.77
79.34
81.86
Earnings per share (EPS)
0.04
0.04
0.03
0.06
0.02
-0.04
0.02
Diluted Earnings per share
0.04
0.04
0.03
0.06
0.02
-0.04
0.02
Operating Profit Margin (Excl OI)
-2.1%
-7.9%
-8.31%
-20.63%
-24.73%
-24.17%
-15.81%
Gross Profit Margin
25.82%
23.94%
18.3%
23.76%
18.09%
-10.12%
19.11%
PAT Margin
15.15%
12.47%
9.2%
24.55%
10.35%
-17.51%
10.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended May 2025 is 8.76%

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended May 2025 is 78.26%

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended May 2025 is 240.00%

stock-summary

Interest

QoQ Growth in quarter ended May 2025 is -8.33%

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

Compare Quarterly Results Of Cannara Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
27.33
11.28
16.05
142.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
27.33
11.28
16.05
142.29%
Raw Material Cost
22.01
4.68
17.33
370.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.06
0.83
0.23
27.71%
Selling and Distribution Expenses
5.72
7.27
-1.55
-21.32%
Other Expenses
-0.09
0.10
-0.19
-190.00%
Total Expenditure (Excl Depreciation)
27.91
13.74
14.17
103.13%
Operating Profit (PBDIT) excl Other Income
-0.57
-2.47
1.90
76.92%
Other Income
0.09
0.00
0.09
Operating Profit (PBDIT)
0.78
-1.89
2.67
141.27%
Interest
1.06
0.83
0.23
27.71%
Exceptional Items
7.34
0.00
7.34
Gross Profit (PBDT)
5.32
6.59
-1.27
-19.27%
Depreciation
1.26
0.57
0.69
121.05%
Profit Before Tax
5.79
-3.30
9.09
275.45%
Tax
1.65
0.05
1.60
3,200.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
4.14
-3.35
7.49
223.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4.14
-3.35
7.49
223.58%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4.14
-3.35
7.49
223.58%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
98.59
-1.26
99.85
7,924.60%
Earnings per share (EPS)
0.04
-0.19
0.23
121.05%
Diluted Earnings per share
0.04
-0.19
0.23
121.05%
Operating Profit Margin (Excl OI)
-2.10%
-21.87%
0.00
19.77%
Gross Profit Margin
25.82%
-24.19%
0.00
50.01%
PAT Margin
15.15%
-29.75%
0.00
44.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2.73 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 8.76%

stock-summary

YoY Growth in quarter ended May 2025 is 40.00% vs 22.64% in May 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.41 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 78.26%

stock-summary

YoY Growth in quarter ended May 2025 is 105.00% vs -31.03% in May 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.07 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 240.00%

stock-summary

YoY Growth in quarter ended May 2025 is 121.21% vs -266.67% in May 2024

Quarterly - Interest
Interest 0.11 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -8.33%

stock-summary

YoY Growth in quarter ended May 2025 is -31.25% vs 14.29% in May 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -2.10%
in May 2025

Figures in %
stock-summary

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

stock-summary

YoY Growth in quarter ended May 2025 has improved from May 2024